Comparative proteomics analysis in different stages of urothelial bladder cancer for identification of potential biomarkers: highlighted role for antioxidant activity.

Tabaei, Samira; Haghshenas, Mohammad Reza; Ariafar, Ali; Gilany, Kambiz; Stensballe, Allan; Farjadian, Shirin; Ghaderi, Abbas

Tabaei, Samira; Haghshenas, Mohammad Reza; Ariafar, Ali; Gilany, Kambiz; Stensballe, Allan; Farjadian, Shirin; Ghaderi, Abbas.

Afiliación

Tabaei S; Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Haghshenas MR; Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Ariafar A; Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Gilany K; Department of Urology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Stensballe A; Integrative Oncology Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.
Farjadian S; Department of Health Science and Technology, Aalborg University, Gistrup, 9260, Denmark.
Ghaderi A; Clinical Cancer Research Center, Aalborg University hospital, Gistrup, 9260, Denmark.

Clin Proteomics ; 20(1): 28, 2023 Jul 27.

Article en En | MEDLINE | ID: mdl-37501157

Palabras clave

Biomarker; Cellular responses; Proteomics; Urothelial bladder cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: Clin Proteomics Año: 2023 Tipo del documento: Article País de afiliación: Irán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google